281 related articles for article (PubMed ID: 2910504)
21. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
Grimm EA; Ramsey KM; Mazumder A; Wilson DJ; Djeu JY; Rosenberg SA
J Exp Med; 1983 Mar; 157(3):884-97. PubMed ID: 6601174
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic characterization of murine lymphokine-activated killer cells.
Owen-Schaub LB; Abraham SR; Hemstreet GP
Cell Immunol; 1986 Dec; 103(2):272-86. PubMed ID: 2879640
[TBL] [Abstract][Full Text] [Related]
23. Natural killer (NK) cell subsets in the mouse. NK-1.1+/LGL-1+ cells restricted to lysing NK targets, whereas NK-1.1+/LGL-1- cells generate lymphokine-activated killer cells.
Mason LH; Mathieson BJ; Ortaldo JR
J Immunol; 1990 Jul; 145(2):751-9. PubMed ID: 2365999
[TBL] [Abstract][Full Text] [Related]
24. Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity.
Vujanovic NL; Herberman RB; Hiserodt JC
Cancer Res; 1988 Feb; 48(4):878-83. PubMed ID: 3257411
[TBL] [Abstract][Full Text] [Related]
25. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of asialo GM1 on alloreactive cytotoxic T lymphocytes and lymphokine-activated killer cells.
Ting CC; Hargrove ME; Wunderlich J; Loh NN
Cell Immunol; 1987 Jan; 104(1):115-25. PubMed ID: 2948673
[TBL] [Abstract][Full Text] [Related]
27. Role of lymphokine-activated killer cells as mediators of veto and natural suppression.
Azuma E; Kaplan J
J Immunol; 1988 Oct; 141(8):2601-6. PubMed ID: 3171179
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells.
Chambers WH; Vujanovic NL; DeLeo AB; Olszowy MW; Herberman RB; Hiserodt JC
J Exp Med; 1989 Apr; 169(4):1373-89. PubMed ID: 2466943
[TBL] [Abstract][Full Text] [Related]
29. Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells.
Vujanovic NL; Herberman RB; Maghazachi AA; Hiserodt JC
J Exp Med; 1988 Jan; 167(1):15-29. PubMed ID: 3257251
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy-induced modulation of natural killer and lymphokine-activated killer cell activity in euthymic and athymic mice.
Gazit Z; Kedar E
Cancer Immunol Immunother; 1994 Apr; 38(4):243-52. PubMed ID: 8168119
[TBL] [Abstract][Full Text] [Related]
31. NK and LAK activities from human marrow progenitors. I. The effects of interleukin-2 and interleukin-1.
Keever CA; Pekle K; Gazzola MV; Collins NH; Gillio A
Cell Immunol; 1990 Mar; 126(1):211-26. PubMed ID: 1689220
[TBL] [Abstract][Full Text] [Related]
32. Comparison of murine lymphokine-activated killer cells, natural killer cells, and cytotoxic T lymphocytes.
Merluzzi VJ
Cell Immunol; 1985 Oct; 95(1):95-104. PubMed ID: 3875426
[TBL] [Abstract][Full Text] [Related]
33. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
[TBL] [Abstract][Full Text] [Related]
34. A phenyl-beta-galactoside-specific monoclonal antibody reactive with murine and rat NK cells.
Miller VE; Lagarde AE; Longenecker BM; Greenberg AH
J Immunol; 1986 Apr; 136(8):2968-74. PubMed ID: 2420880
[TBL] [Abstract][Full Text] [Related]
35. Characterization of natural killer cells and their precursors in the murine bone marrow.
Silvennoinen O; Renkonen R; Hurme M
Cell Immunol; 1986 Aug; 101(1):1-7. PubMed ID: 3527445
[TBL] [Abstract][Full Text] [Related]
36. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
[TBL] [Abstract][Full Text] [Related]
37. Interleukin 3 is a major negative regulator of the generation of natural killer cells from bone marrow precursors.
Kalland T
J Immunol; 1986 Oct; 137(7):2268-71. PubMed ID: 2876040
[TBL] [Abstract][Full Text] [Related]
38. Role of asialo-GM1-positive lymphoid cells in mediating the toxic effects of recombinant IL-2 in mice.
Gately MK; Anderson TD; Hayes TJ
J Immunol; 1988 Jul; 141(1):189-200. PubMed ID: 3259967
[TBL] [Abstract][Full Text] [Related]
39. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
40. Generation of large granular T lymphocytes in vivo during viral infection.
Biron CA; Natuk RJ; Welsh RM
J Immunol; 1986 Mar; 136(6):2280-6. PubMed ID: 3485144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
